These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

151 related items for PubMed ID: 9596112

  • 1. Effects of a 5-lipoxygenase inhibitor, ABT-761, on exercise-induced bronchoconstriction and urinary LTE4 in asthmatic patients.
    Lehnigk B, Rabe KF, Dent G, Herst RS, Carpentier PJ, Magnussen H.
    Eur Respir J; 1998 Mar; 11(3):617-23. PubMed ID: 9596112
    [Abstract] [Full Text] [Related]

  • 2. The effect of ABT-761, a novel 5-lipoxygenase inhibitor, on exercise- and adenosine-induced bronchoconstriction in asthmatic subjects.
    Van Schoor J, Joos GF, Kips JC, Drajesk JF, Carpentier PJ, Pauwels RA.
    Am J Respir Crit Care Med; 1997 Mar; 155(3):875-80. PubMed ID: 9117020
    [Abstract] [Full Text] [Related]

  • 3. Increased urinary excretion of LTE4 after exercise and attenuation of exercise-induced bronchospasm by montelukast, a cysteinyl leukotriene receptor antagonist.
    Reiss TF, Hill JB, Harman E, Zhang J, Tanaka WK, Bronsky E, Guerreiro D, Hendeles L.
    Thorax; 1997 Dec; 52(12):1030-5. PubMed ID: 9516894
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Effect of 5-lipoxygenase inhibition on bronchoconstriction and airway inflammation in nocturnal asthma.
    Wenzel SE, Trudeau JB, Kaminsky DA, Cohn J, Martin RJ, Westcott JY.
    Am J Respir Crit Care Med; 1995 Sep; 152(3):897-905. PubMed ID: 7663802
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Effect of a 5-lipoxygenase inhibitor on leukotriene generation and airway responses after allergen challenge in asthmatic patients.
    Hui KP, Taylor IK, Taylor GW, Rubin P, Kesterson J, Barnes NC, Barnes PJ.
    Thorax; 1991 Mar; 46(3):184-9. PubMed ID: 1851340
    [Abstract] [Full Text] [Related]

  • 13. Effect of terbutaline on hyperpnoea-induced bronchoconstriction and urinary club cell protein 16 in athletes.
    Simpson AJ, Tufvesson E, Anderson SD, Romer LM, Bjermer L, Kippelen P.
    J Appl Physiol (1985); 2013 Nov; 115(10):1450-6. PubMed ID: 24030662
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Protection against exercise-induced bronchoconstriction by montelukast in aspirin-sensitive and aspirin-tolerant patients with asthma.
    Mastalerz L, Gawlewicz-Mroczka A, Nizankowska E, Cmiel A, Szczeklik A.
    Clin Exp Allergy; 2002 Sep; 32(9):1360-5. PubMed ID: 12220476
    [Abstract] [Full Text] [Related]

  • 18. Ascorbic acid supplementation attenuates exercise-induced bronchoconstriction in patients with asthma.
    Tecklenburg SL, Mickleborough TD, Fly AD, Bai Y, Stager JM.
    Respir Med; 2007 Aug; 101(8):1770-8. PubMed ID: 17412579
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Inhibition of exercise-induced bronchoconstriction by MK-571, a potent leukotriene D4-receptor antagonist.
    Manning PJ, Watson RM, Margolskee DJ, Williams VC, Schwartz JI, O'Byrne PM.
    N Engl J Med; 1990 Dec 20; 323(25):1736-9. PubMed ID: 2174121
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.